Correction: Financing the introduction of new vaccines to the national immunisation programme in China: challenges and options for action

Unknown · 2025

Read Correction: Financing the introduction of new vaccines to the national immunisation programme in China: challenges and options for action by Unknown (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12742120.txt.

Description

A correction notice fixes two vaccine prices in a study of how China finances new additions to its national immunisation programme. In the China 2024 column of the prices table, the BCG vaccine should read US$0.69 per dose instead of US$3.44. The diphtheria-tetanus vaccine should read US$0.09 instead of US$0.36. Both errors stemmed from a miscalculation. The notice states that the mistakes are confined to that table and leave the study's main findings, analyses, and conclusions untouched.

Catalog record

CREATORUnknown
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12742120

Browse the full library · About the Tower of Babel